Results 211 to 220 of about 103,888 (259)

Thrombotic Thrombocytopenic Purpura as a Rare Stroke Mimic. [PDF]

open access: yesDtsch Arztebl Int
Mattern J, Jacobi B, Munder M.
europepmc   +1 more source

Prognostic relevance of early clinical and laboratory findings in immune-mediated thrombotic thrombocytopenic purpura. [PDF]

open access: yesRes Pract Thromb Haemost
Hamamura A   +9 more
europepmc   +1 more source

THROMBOHEMOLYTIC THROMBOCYTOPENIC PURPURA

Archives of Internal Medicine, 1954
THE DISEASE thrombotic thrombocytopenic purpura refers to a condition characterized by an unusual triad: hemolytic anemia, thrombocytopenic purpura, and multiple hyaline thrombi throughout the small vessels of the body. The occurrence of thrombi in cranial blood vessels gives rise to the characteristic cerebral symptoms.
E, ADELSON   +2 more
openaire   +2 more sources

Diagnostic accuracy of the PLASMIC score in patients with suspected thrombotic thrombocytopenic purpura: A systematic review and meta‐analysis

Transfusion, 2020
The PLASMIC score was developed to identify patients with thrombotic microangiopathy who are most likely to have immune thrombotic thrombocytopenic purpura (TTP) and benefit from therapeutic plasma exchange (TPE).
Koosha Paydary   +4 more
semanticscholar   +1 more source

Immune Thrombocytopenic Purpura

Hematology/Oncology Clinics of North America, 2007
Immune thrombocytopenic purpura (ITP) is an autoantibody-mediated thrombocytopenic disorder in which accelerated destruction of platelets occurs; platelet production may also be impaired by these antibodies. ITP is characterized by mucocutaneous bleeding. Rarely, more severe hemorrhages, such as intracranial hemorrhage, may occur. Traditional therapies,
Bethan, Psaila, James B, Bussel
openaire   +2 more sources

Immune Thrombocytopenic Purpura

New England Journal of Medicine, 2002
Immune thrombocytopenic purpura, which may lead to bleeding, is typically caused by antibodies directed against the platelet glycoprotein IIb/IIIa complex. Since the management of the disorder is different for children and adults, the authors of this up-to-date review provide separate sections on the two age groups.
Douglas B, Cines, Victor S, Blanchette
openaire   +4 more sources

Thrombotic Thrombocytopenic Purpura

Pediatric Emergency Care, 2011
In 1924, Dr Eli Moschcowitz described a 16-year-old adolescent girl with abrupt onset of petechiae, hemolytic anemia, followed by paralysis, coma, and death. Autopsy showed widespread hyaline thrombi in the terminal arterioles and capillaries of various organs. The syndrome described by Moschowitz is now known as thrombotic thrombocytopenic purpura.
Alex, Koyfman   +2 more
openaire   +2 more sources

Congenital thrombocytopenic purpura

The Journal of Pediatrics, 1947
Summary Congenital thrombocytopenic purpura has occurred as a familial condition in three successive children of a mother previously splenectomized for thrombocytopenic purpura. In each of these children there has been a gradual spontaneous recovery to a normal blood picture during the first 2 months of life, and following recovery there has been no ...
J, TALMADGE, B, BERMAN
openaire   +2 more sources

NEONATAL THROMBOCYTOPENIC PURPURA

Pediatrics, 1956
A case of neonatal thrombocytopenic purpura in the newborn infant of a mother with idiopathic thrombocytopenic purpura is reported. The mother and the baby both had platelet autoagglutinins, and isoagglutinins were present for each other's platelets. The infant's agglutinins had disappeared by the age of 3 months.
E J, SCHOEN, A L, KING, R T, DUANE
openaire   +2 more sources

First‐in‐patient study of hetrombopag in patients with chronic idiopathic thrombocytopenic purpura

Journal of Thrombosis and Haemostasis, 2020
Idiopathic thrombocytopenic purpura (ITP) especially refractory and (or) relapsed ITP, is a serious and global health burden and its clinical treatment is far from being satisfied.
Zhenlei Wang   +10 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy